Key considerations for the development of novel mRNA candidate vaccines in LMICs: A WHO/MPP mRNA Technology Transfer Programme meeting report

Gsell, Pierre-Stéphane; Giersing, Birgitte; Gottlieb, Sami; Wilder-Smith, Annelies; Wu, Lindsey; Friede, Martin

doi:10.1016/j.vaccine.2023.10.027

Vaccine

2023

DOI: 10.1016/j.vaccine.2023.10.027

|View full text |Cite

Key considerations for the development of novel mRNA candidate vaccines in LMICs: A WHO/MPP mRNA Technology Transfer Programme meeting report

Pierre-Stéphane Gsell,

Birgitte Giersing,

Sami Gottlieb

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Article4

Relationship

Self Cite0

Independent4

Authors

Journals

Cited by 4 publications

References 53 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Preclinical evaluation in hamster model of the mRNA COVID-19 vaccine candidate AfriVac 2121 (Wuhan) produced under the WHO/MPP mRNA Technology Transfer Programme

Bernadin,

Cochin,

Driouich

et al. 2024

Vaccine

View full text Add to dashboard Cite

Preclinical evaluation in hamster model of the mRNA COVID-19 vaccine candidate AfriVac 2121 (Wuhan) produced under the WHO/MPP mRNA Technology Transfer Programme

Bernadin,

Cochin,

Driouich

et al. 2024

Vaccine

View full text Add to dashboard Cite

Advancing influenza vaccines: A review of next-generation candidates and their potential for global health impact

Taaffe,

Ostrowsky,

Mott

et al. 2024

Vaccine

View full text Add to dashboard Cite

mRNA vaccine politics: responsible governance coordination for vaccine innovation in times of urgency

Sideri

2024

Journal of Responsible Innovation

View full text Add to dashboard Cite

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Key considerations for the development of novel mRNA candidate vaccines in LMICs: A WHO/MPP mRNA Technology Transfer Programme meeting report

Cited by 4 publications

References 53 publications

Preclinical evaluation in hamster model of the mRNA COVID-19 vaccine candidate AfriVac 2121 (Wuhan) produced under the WHO/MPP mRNA Technology Transfer Programme

Preclinical evaluation in hamster model of the mRNA COVID-19 vaccine candidate AfriVac 2121 (Wuhan) produced under the WHO/MPP mRNA Technology Transfer Programme

Advancing influenza vaccines: A review of next-generation candidates and their potential for global health impact

mRNA vaccine politics: responsible governance coordination for vaccine innovation in times of urgency

Contact Info

Product

Resources

About